| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrology | 7 | 2023 | 263 | 1.730 |
Why?
|
| Conservation of Natural Resources | 8 | 2024 | 204 | 1.610 |
Why?
|
| Kidney Transplantation | 12 | 2023 | 4251 | 1.290 |
Why?
|
| Nephrotic Syndrome | 11 | 2023 | 389 | 1.270 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 5 | 2023 | 357 | 1.240 |
Why?
|
| Renal Replacement Therapy | 11 | 2019 | 257 | 1.090 |
Why?
|
| Ecosystem | 5 | 2024 | 474 | 0.970 |
Why?
|
| Carnivora | 3 | 2014 | 29 | 0.970 |
Why?
|
| Kidney Failure, Chronic | 10 | 2021 | 2538 | 0.960 |
Why?
|
| Canidae | 3 | 2014 | 4 | 0.930 |
Why?
|
| Biodiversity | 4 | 2024 | 341 | 0.900 |
Why?
|
| Leukopenia | 1 | 2023 | 212 | 0.890 |
Why?
|
| Acute Kidney Injury | 10 | 2023 | 1972 | 0.830 |
Why?
|
| Glomerulonephritis | 3 | 2019 | 372 | 0.820 |
Why?
|
| Kidney Diseases | 8 | 2022 | 2149 | 0.800 |
Why?
|
| Peritoneal Dialysis | 3 | 2021 | 146 | 0.780 |
Why?
|
| Animals, Wild | 2 | 2023 | 90 | 0.750 |
Why?
|
| Antilymphocyte Serum | 2 | 2023 | 492 | 0.680 |
Why?
|
| Immunosuppressive Agents | 6 | 2023 | 4149 | 0.650 |
Why?
|
| Hemofiltration | 3 | 2015 | 57 | 0.590 |
Why?
|
| Renal Insufficiency, Chronic | 7 | 2023 | 2208 | 0.570 |
Why?
|
| Catheter-Related Infections | 2 | 2021 | 252 | 0.540 |
Why?
|
| Schistosoma haematobium | 1 | 2015 | 11 | 0.540 |
Why?
|
| Schistosomiasis haematobia | 1 | 2015 | 15 | 0.540 |
Why?
|
| Recreation | 2 | 2015 | 115 | 0.540 |
Why?
|
| Urine | 2 | 2015 | 370 | 0.540 |
Why?
|
| Catheters, Indwelling | 2 | 2018 | 426 | 0.540 |
Why?
|
| Renal Dialysis | 10 | 2021 | 1786 | 0.510 |
Why?
|
| Lions | 1 | 2014 | 3 | 0.500 |
Why?
|
| Human Activities | 1 | 2014 | 25 | 0.490 |
Why?
|
| Animals, Zoo | 1 | 2014 | 15 | 0.480 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2009 | 110 | 0.480 |
Why?
|
| Hematuria | 1 | 2015 | 235 | 0.480 |
Why?
|
| Housing, Animal | 1 | 2014 | 48 | 0.470 |
Why?
|
| Graft Rejection | 6 | 2023 | 4397 | 0.460 |
Why?
|
| Child | 56 | 2023 | 77709 | 0.460 |
Why?
|
| Pediatrics | 6 | 2021 | 3475 | 0.460 |
Why?
|
| Urogenital Abnormalities | 3 | 2021 | 261 | 0.450 |
Why?
|
| Kidney | 13 | 2023 | 7186 | 0.440 |
Why?
|
| Urinary Tract | 4 | 2021 | 309 | 0.430 |
Why?
|
| Virus Diseases | 1 | 2019 | 711 | 0.430 |
Why?
|
| Blood Component Removal | 1 | 2013 | 125 | 0.410 |
Why?
|
| Sexual Behavior, Animal | 2 | 2012 | 113 | 0.410 |
Why?
|
| Body Size | 1 | 2014 | 461 | 0.390 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 1107 | 0.390 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1401 | 0.370 |
Why?
|
| Nephritis | 3 | 2023 | 159 | 0.350 |
Why?
|
| Child, Preschool | 33 | 2020 | 41006 | 0.320 |
Why?
|
| Levamisole | 1 | 2008 | 35 | 0.320 |
Why?
|
| Child, Hospitalized | 2 | 2019 | 174 | 0.310 |
Why?
|
| Sirolimus | 1 | 2014 | 1564 | 0.300 |
Why?
|
| BK Virus | 1 | 2008 | 129 | 0.290 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1738 | 0.290 |
Why?
|
| Tuberous Sclerosis | 1 | 2014 | 1029 | 0.280 |
Why?
|
| Adolescent | 40 | 2023 | 85781 | 0.280 |
Why?
|
| Polyomavirus Infections | 1 | 2008 | 197 | 0.270 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1881 | 0.260 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2109 | 0.260 |
Why?
|
| Tumor Virus Infections | 1 | 2008 | 452 | 0.250 |
Why?
|
| Plasmapheresis | 2 | 2023 | 211 | 0.250 |
Why?
|
| Acacia | 1 | 2004 | 2 | 0.250 |
Why?
|
| Germination | 1 | 2004 | 12 | 0.250 |
Why?
|
| Antelopes | 1 | 2024 | 2 | 0.250 |
Why?
|
| Review Literature as Topic | 1 | 2006 | 336 | 0.240 |
Why?
|
| Fabaceae | 1 | 2004 | 103 | 0.230 |
Why?
|
| Animals, Domestic | 1 | 2023 | 56 | 0.230 |
Why?
|
| Epispadias | 1 | 2023 | 18 | 0.230 |
Why?
|
| Pedigree | 7 | 2020 | 4644 | 0.230 |
Why?
|
| Infant | 23 | 2020 | 35136 | 0.230 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 804 | 0.220 |
Why?
|
| Animal Welfare | 3 | 2023 | 22 | 0.220 |
Why?
|
| Humans | 86 | 2023 | 744343 | 0.220 |
Why?
|
| Citric Acid | 3 | 2013 | 126 | 0.220 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3843 | 0.220 |
Why?
|
| Fires | 1 | 2004 | 173 | 0.220 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2006 | 523 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 1000 | 0.210 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2002 | 39 | 0.210 |
Why?
|
| Environment | 1 | 2008 | 1124 | 0.210 |
Why?
|
| Galactose | 2 | 2015 | 306 | 0.210 |
Why?
|
| Bladder Exstrophy | 1 | 2023 | 107 | 0.210 |
Why?
|
| Femur Head Necrosis | 1 | 2022 | 132 | 0.200 |
Why?
|
| Central Nervous System Diseases | 1 | 2006 | 518 | 0.200 |
Why?
|
| Nephrocalcinosis | 2 | 2017 | 48 | 0.200 |
Why?
|
| Botswana | 2 | 2015 | 1040 | 0.200 |
Why?
|
| Steroids | 3 | 2020 | 930 | 0.200 |
Why?
|
| Mycophenolic Acid | 1 | 2023 | 343 | 0.200 |
Why?
|
| Drug Resistance | 4 | 2019 | 1609 | 0.200 |
Why?
|
| Amniotic Fluid | 2 | 2001 | 370 | 0.190 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2021 | 427 | 0.190 |
Why?
|
| Thrombosis | 1 | 2015 | 2968 | 0.190 |
Why?
|
| Population Density | 3 | 2015 | 196 | 0.190 |
Why?
|
| Lupus Nephritis | 1 | 2004 | 310 | 0.190 |
Why?
|
| Consensus | 3 | 2023 | 2959 | 0.190 |
Why?
|
| Hypertension | 5 | 2023 | 8480 | 0.180 |
Why?
|
| Virus Replication | 1 | 2008 | 2534 | 0.180 |
Why?
|
| Creatinine | 3 | 2020 | 1919 | 0.180 |
Why?
|
| Glycogen Storage Disease Type I | 2 | 2014 | 53 | 0.170 |
Why?
|
| Glucocorticoids | 3 | 2019 | 2107 | 0.170 |
Why?
|
| Urethra | 1 | 2001 | 408 | 0.170 |
Why?
|
| Peritonitis | 1 | 2021 | 365 | 0.160 |
Why?
|
| Immunoglobulin A | 2 | 2023 | 992 | 0.160 |
Why?
|
| Nephrosis, Lipoid | 1 | 1998 | 51 | 0.160 |
Why?
|
| Infusions, Intralesional | 1 | 2018 | 3 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.160 |
Why?
|
| Male | 43 | 2023 | 350118 | 0.160 |
Why?
|
| Urinary Bladder | 2 | 2023 | 1172 | 0.160 |
Why?
|
| Oligohydramnios | 1 | 2018 | 35 | 0.160 |
Why?
|
| South Africa | 5 | 2015 | 1731 | 0.160 |
Why?
|
| Hot Temperature | 1 | 2004 | 1354 | 0.160 |
Why?
|
| Poisoning | 1 | 2019 | 249 | 0.160 |
Why?
|
| Female | 50 | 2023 | 380194 | 0.150 |
Why?
|
| Infant, Newborn | 15 | 2020 | 25625 | 0.150 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1998 | 66 | 0.150 |
Why?
|
| Retrospective Studies | 16 | 2023 | 77449 | 0.150 |
Why?
|
| Escherichia coli O157 | 1 | 1997 | 54 | 0.150 |
Why?
|
| Nephritis, Interstitial | 1 | 1998 | 156 | 0.150 |
Why?
|
| Hypertension, Renovascular | 1 | 1997 | 123 | 0.150 |
Why?
|
| Quality Improvement | 4 | 2020 | 3749 | 0.150 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 196 | 0.140 |
Why?
|
| Diarrhea | 1 | 2023 | 1348 | 0.140 |
Why?
|
| Amnion | 1 | 2018 | 209 | 0.140 |
Why?
|
| Age of Onset | 5 | 2019 | 3271 | 0.140 |
Why?
|
| Nephrolithiasis | 1 | 2017 | 110 | 0.140 |
Why?
|
| Drug Therapy, Combination | 3 | 2020 | 6489 | 0.140 |
Why?
|
| Salmonella Infections | 1 | 1997 | 173 | 0.140 |
Why?
|
| Animals | 21 | 2024 | 168757 | 0.130 |
Why?
|
| Panthera | 1 | 2015 | 2 | 0.130 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1998 | 288 | 0.130 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 514 | 0.130 |
Why?
|
| Population Dynamics | 2 | 2014 | 302 | 0.130 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1995 | 42 | 0.130 |
Why?
|
| Marfan Syndrome | 1 | 1997 | 240 | 0.130 |
Why?
|
| Geography | 2 | 2014 | 669 | 0.130 |
Why?
|
| Erythropoietin | 1 | 2019 | 726 | 0.130 |
Why?
|
| Genetic Markers | 3 | 2017 | 2634 | 0.130 |
Why?
|
| Registries | 8 | 2017 | 8089 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 4186 | 0.130 |
Why?
|
| Buffaloes | 1 | 2014 | 12 | 0.130 |
Why?
|
| Decision Trees | 1 | 2016 | 506 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2022 | 63114 | 0.120 |
Why?
|
| Colitis | 1 | 2023 | 1170 | 0.120 |
Why?
|
| Livestock | 1 | 2014 | 19 | 0.120 |
Why?
|
| Predatory Behavior | 1 | 2014 | 26 | 0.120 |
Why?
|
| Africa | 2 | 2024 | 673 | 0.120 |
Why?
|
| Mozambique | 1 | 2014 | 54 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 17446 | 0.120 |
Why?
|
| Patient Care | 1 | 2020 | 640 | 0.120 |
Why?
|
| Standard of Care | 1 | 2018 | 564 | 0.120 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 299 | 0.120 |
Why?
|
| Biomass | 1 | 2014 | 125 | 0.120 |
Why?
|
| Mutation | 7 | 2020 | 29786 | 0.120 |
Why?
|
| Recurrence | 2 | 2023 | 8340 | 0.120 |
Why?
|
| Immunosorbent Techniques | 1 | 2013 | 184 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
| Fetal Diseases | 2 | 2018 | 903 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2019 | 1301 | 0.110 |
Why?
|
| Social Dominance | 2 | 2012 | 38 | 0.110 |
Why?
|
| Prospective Studies | 12 | 2023 | 53288 | 0.110 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2012 | 42 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.110 |
Why?
|
| Quality of Life | 4 | 2023 | 12804 | 0.110 |
Why?
|
| Inbreeding | 1 | 2012 | 49 | 0.110 |
Why?
|
| Medication Therapy Management | 1 | 2013 | 127 | 0.110 |
Why?
|
| Solutions | 1 | 2013 | 426 | 0.100 |
Why?
|
| Plasma Exchange | 1 | 2013 | 152 | 0.100 |
Why?
|
| Urologic Diseases | 1 | 2014 | 244 | 0.100 |
Why?
|
| Environment Design | 1 | 2014 | 178 | 0.100 |
Why?
|
| Pharmaceutical Services | 1 | 2013 | 140 | 0.100 |
Why?
|
| Medication Reconciliation | 1 | 2013 | 151 | 0.100 |
Why?
|
| Hypocalcemia | 1 | 2013 | 191 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2017 | 5985 | 0.100 |
Why?
|
| Blood Volume | 1 | 2013 | 565 | 0.100 |
Why?
|
| Acute Disease | 2 | 2019 | 7149 | 0.100 |
Why?
|
| Hemoglobins | 1 | 1997 | 1534 | 0.100 |
Why?
|
| Proteinuria | 3 | 2023 | 658 | 0.100 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1990 | 79 | 0.090 |
Why?
|
| North America | 2 | 2017 | 1249 | 0.090 |
Why?
|
| Cohort Studies | 9 | 2019 | 40561 | 0.090 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 684 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 288 | 0.090 |
Why?
|
| Prednisone | 1 | 1995 | 1574 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2019 | 7880 | 0.090 |
Why?
|
| Research Report | 1 | 2013 | 355 | 0.090 |
Why?
|
| Anemia | 1 | 2019 | 1506 | 0.090 |
Why?
|
| Young Adult | 10 | 2019 | 56430 | 0.090 |
Why?
|
| Pharmacists | 2 | 2023 | 248 | 0.090 |
Why?
|
| Extinction, Biological | 1 | 2009 | 32 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.090 |
Why?
|
| Endangered Species | 2 | 2023 | 19 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3023 | 0.080 |
Why?
|
| Graft Survival | 3 | 2023 | 3737 | 0.080 |
Why?
|
| Incidence | 4 | 2018 | 20947 | 0.080 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2009 | 113 | 0.080 |
Why?
|
| South America | 1 | 2009 | 181 | 0.080 |
Why?
|
| Population Growth | 1 | 2008 | 52 | 0.080 |
Why?
|
| Insulin | 2 | 2001 | 6580 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 4 | 2023 | 2170 | 0.080 |
Why?
|
| Radiography | 3 | 2022 | 7023 | 0.080 |
Why?
|
| Patient Care Team | 2 | 2016 | 2531 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39050 | 0.080 |
Why?
|
| Food Contamination | 1 | 2009 | 188 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3610 | 0.080 |
Why?
|
| Genetic Association Studies | 4 | 2018 | 2703 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 2795 | 0.070 |
Why?
|
| Patient Selection | 1 | 2019 | 4215 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2266 | 0.070 |
Why?
|
| Asia | 1 | 2009 | 610 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 12959 | 0.070 |
Why?
|
| Infant Formula | 1 | 2009 | 199 | 0.070 |
Why?
|
| Risk Factors | 7 | 2023 | 72290 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3647 | 0.070 |
Why?
|
| Heredity | 2 | 2017 | 154 | 0.070 |
Why?
|
| Nutritional Support | 1 | 2008 | 168 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 14722 | 0.070 |
Why?
|
| Triazines | 1 | 2009 | 315 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2023 | 4468 | 0.070 |
Why?
|
| Prevalence | 1 | 2023 | 15226 | 0.070 |
Why?
|
| Nausea | 1 | 2009 | 673 | 0.070 |
Why?
|
| Self Report | 1 | 2017 | 3558 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2014 | 5078 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 1965 | 0.070 |
Why?
|
| Multiple Organ Failure | 2 | 2005 | 390 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.060 |
Why?
|
| Medicare | 1 | 2023 | 6566 | 0.060 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 941 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2014 | 3589 | 0.060 |
Why?
|
| Antiporters | 2 | 2014 | 277 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4567 | 0.060 |
Why?
|
| United States | 10 | 2023 | 69872 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2014 | 5102 | 0.060 |
Why?
|
| Viremia | 1 | 2008 | 736 | 0.060 |
Why?
|
| Microtubules | 1 | 1990 | 1090 | 0.060 |
Why?
|
| Erythrocytes | 2 | 2013 | 2455 | 0.060 |
Why?
|
| Anticoagulants | 2 | 2013 | 4599 | 0.060 |
Why?
|
| Disease Progression | 4 | 2023 | 13284 | 0.060 |
Why?
|
| Catheterization, Peripheral | 1 | 2007 | 345 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2915 | 0.060 |
Why?
|
| Health Status | 1 | 2017 | 4034 | 0.060 |
Why?
|
| Endosomes | 2 | 1997 | 520 | 0.060 |
Why?
|
| Membranes, Artificial | 1 | 2005 | 378 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 2008 | 963 | 0.060 |
Why?
|
| Sclerosis | 1 | 2023 | 213 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 693 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9648 | 0.060 |
Why?
|
| Heterozygote | 3 | 2020 | 2804 | 0.050 |
Why?
|
| Vertebrates | 1 | 2024 | 227 | 0.050 |
Why?
|
| Anxiety | 2 | 2017 | 4297 | 0.050 |
Why?
|
| Plants | 1 | 2024 | 316 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 201 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2019 | 1654 | 0.050 |
Why?
|
| Europe | 1 | 2009 | 3339 | 0.050 |
Why?
|
| Remission Induction | 1 | 2008 | 2386 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 440 | 0.050 |
Why?
|
| Agriculture | 1 | 2023 | 190 | 0.050 |
Why?
|
| Biopsy | 2 | 2019 | 6756 | 0.050 |
Why?
|
| Urinalysis | 1 | 2004 | 369 | 0.050 |
Why?
|
| Infant Food | 1 | 2002 | 141 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5319 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9274 | 0.050 |
Why?
|
| Headache | 1 | 2009 | 1226 | 0.050 |
Why?
|
| Adult | 18 | 2023 | 214055 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1850 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2008 | 1530 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1790 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Energy Intake | 1 | 2008 | 2148 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2001 | 124 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12208 | 0.050 |
Why?
|
| Phenotype | 5 | 2018 | 16365 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2001 | 732 | 0.050 |
Why?
|
| Hospitals, Pediatric | 2 | 2019 | 1775 | 0.050 |
Why?
|
| Prognosis | 5 | 2019 | 29063 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 778 | 0.040 |
Why?
|
| Edema | 1 | 2004 | 789 | 0.040 |
Why?
|
| Glomerular Basement Membrane | 1 | 2019 | 33 | 0.040 |
Why?
|
| Risk Assessment | 5 | 2019 | 23338 | 0.040 |
Why?
|
| Survival Rate | 5 | 2017 | 12788 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2002 | 251 | 0.040 |
Why?
|
| Chickenpox | 1 | 2000 | 131 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 5137 | 0.040 |
Why?
|
| Troponin | 1 | 2003 | 524 | 0.040 |
Why?
|
| Exanthema | 1 | 2004 | 501 | 0.040 |
Why?
|
| Acyclovir | 1 | 2000 | 272 | 0.040 |
Why?
|
| Forms and Records Control | 1 | 2019 | 160 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 1620 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1855 | 0.040 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 170 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 519 | 0.040 |
Why?
|
| Algorithms | 2 | 2019 | 13881 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 712 | 0.040 |
Why?
|
| Information Services | 1 | 2019 | 244 | 0.040 |
Why?
|
| Mammals | 1 | 2024 | 1143 | 0.040 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1998 | 51 | 0.040 |
Why?
|
| Reimbursement, Incentive | 1 | 2023 | 540 | 0.040 |
Why?
|
| Shiga Toxin 2 | 1 | 1997 | 21 | 0.040 |
Why?
|
| Shiga Toxin 1 | 1 | 1997 | 42 | 0.040 |
Why?
|
| Heparin | 1 | 2005 | 1637 | 0.040 |
Why?
|
| Opossums | 1 | 1997 | 106 | 0.040 |
Why?
|
| Cimetidine | 1 | 1997 | 78 | 0.040 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 1998 | 153 | 0.040 |
Why?
|
| Amoxicillin | 1 | 1998 | 170 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 454 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 712 | 0.040 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1997 | 225 | 0.040 |
Why?
|
| Lymphoma | 1 | 2006 | 1877 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1997 | 171 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1997 | 475 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1580 | 0.040 |
Why?
|
| Seizures | 1 | 2009 | 2859 | 0.040 |
Why?
|
| Kidney Calculi | 1 | 2001 | 465 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21746 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2002 | 763 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 13989 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2023 | 1904 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2019 | 1590 | 0.030 |
Why?
|
| Penicillins | 1 | 1998 | 380 | 0.030 |
Why?
|
| Kidney Medulla | 1 | 1996 | 182 | 0.030 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2015 | 90 | 0.030 |
Why?
|
| Podocytes | 1 | 2019 | 396 | 0.030 |
Why?
|
| Aquaporins | 1 | 1996 | 174 | 0.030 |
Why?
|
| Dextrans | 1 | 1997 | 595 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2023 | 4776 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1997 | 416 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1998 | 880 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.030 |
Why?
|
| Actuarial Analysis | 1 | 1995 | 378 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2014 | 73 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2018 | 646 | 0.030 |
Why?
|
| Empathy | 1 | 2019 | 474 | 0.030 |
Why?
|
| Genes, Wilms Tumor | 1 | 2014 | 94 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2012 | 9849 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1785 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 867 | 0.030 |
Why?
|
| Protein Binding | 2 | 2020 | 9386 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
| Cell Line | 2 | 2019 | 15997 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 491 | 0.030 |
Why?
|
| Motivation | 1 | 2023 | 1971 | 0.030 |
Why?
|
| Benchmarking | 1 | 2020 | 1042 | 0.030 |
Why?
|
| Time | 1 | 2015 | 542 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 520 | 0.030 |
Why?
|
| Hemodialysis Solutions | 1 | 2012 | 8 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Sex Factors | 1 | 2007 | 10397 | 0.030 |
Why?
|
| Pregnancy | 4 | 2018 | 29144 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 440 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10252 | 0.030 |
Why?
|
| Endocytosis | 1 | 1997 | 985 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 1801 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 1076 | 0.030 |
Why?
|
| Epithelium | 1 | 1997 | 1679 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 3588 | 0.030 |
Why?
|
| Dogs | 2 | 2014 | 3912 | 0.030 |
Why?
|
| Time Factors | 3 | 2007 | 40075 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1993 | 325 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 3527 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 1997 | 931 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15076 | 0.020 |
Why?
|
| Syndrome | 1 | 2018 | 3251 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 2104 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2001 | 1184 | 0.020 |
Why?
|
| Genotype | 2 | 2017 | 12951 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1997 | 1470 | 0.020 |
Why?
|
| Cattle | 1 | 1997 | 3922 | 0.020 |
Why?
|
| Informed Consent | 1 | 2018 | 995 | 0.020 |
Why?
|
| Lisinopril | 1 | 2011 | 54 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1997 | 8301 | 0.020 |
Why?
|
| Alternaria | 1 | 1991 | 44 | 0.020 |
Why?
|
| Inappropriate Prescribing | 1 | 2013 | 202 | 0.020 |
Why?
|
| Ion Channels | 1 | 1996 | 1056 | 0.020 |
Why?
|
| Pain | 2 | 2017 | 4986 | 0.020 |
Why?
|
| Polypharmacy | 1 | 2013 | 294 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1990 | 313 | 0.020 |
Why?
|
| Microtubule Proteins | 1 | 1990 | 61 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6933 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 1993 | 936 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2003 | 2788 | 0.020 |
Why?
|
| Fatigue | 1 | 2017 | 1531 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 1425 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2018 | 1695 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 683 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3147 | 0.020 |
Why?
|
| Losartan | 1 | 2011 | 299 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2011 | 343 | 0.020 |
Why?
|
| Sports | 1 | 2015 | 688 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2013 | 1460 | 0.020 |
Why?
|
| Lysosomes | 1 | 1994 | 893 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1996 | 2025 | 0.020 |
Why?
|
| Cost Savings | 1 | 2013 | 926 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 1210 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2011 | 451 | 0.020 |
Why?
|
| Calcium | 1 | 2001 | 5756 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2000 | 2987 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 950 | 0.020 |
Why?
|
| Reproduction | 1 | 2012 | 668 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1993 | 1572 | 0.020 |
Why?
|
| Kinetics | 2 | 1996 | 6473 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1990 | 981 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
| Critical Illness | 2 | 2009 | 2670 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1996 | 3748 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1504 | 0.020 |
Why?
|
| Logistic Models | 1 | 2001 | 13408 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3444 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 24260 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
| Drug Costs | 1 | 2013 | 1105 | 0.020 |
Why?
|
| Muscles | 1 | 1990 | 1614 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15295 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15540 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14557 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2019 | 7729 | 0.020 |
Why?
|
| Pyrroles | 1 | 2011 | 1146 | 0.020 |
Why?
|
| Rabbits | 1 | 1990 | 4894 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1518 | 0.010 |
Why?
|
| Allergens | 1 | 1991 | 1320 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2011 | 979 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 191 | 0.010 |
Why?
|
| Polymers | 1 | 1990 | 1621 | 0.010 |
Why?
|
| China | 1 | 2009 | 2248 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 214 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26385 | 0.010 |
Why?
|
| Mice | 2 | 2020 | 81183 | 0.010 |
Why?
|
| Demography | 1 | 2007 | 1656 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2008 | 981 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 549 | 0.010 |
Why?
|
| Amniocentesis | 1 | 2001 | 116 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2003 | 694 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 5391 | 0.010 |
Why?
|
| Swine | 1 | 1990 | 5917 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2001 | 379 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6365 | 0.010 |
Why?
|
| Karyotyping | 1 | 2001 | 1243 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2001 | 405 | 0.010 |
Why?
|
| Automation | 1 | 2001 | 584 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6196 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 1726 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1730 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5952 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1998 | 103 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 1585 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2003 | 859 | 0.010 |
Why?
|
| Depression | 1 | 2017 | 7766 | 0.010 |
Why?
|
| Middle Aged | 3 | 2014 | 213383 | 0.010 |
Why?
|
| Sulfates | 1 | 1998 | 390 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1998 | 313 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6544 | 0.010 |
Why?
|
| Aquaporin 6 | 1 | 1996 | 45 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9959 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 437 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12245 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 802 | 0.010 |
Why?
|
| Chlorides | 1 | 1998 | 667 | 0.010 |
Why?
|
| Aquaporin 2 | 1 | 1996 | 148 | 0.010 |
Why?
|
| Body Water | 1 | 1996 | 343 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20129 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 337 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 590 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 4982 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 2255 | 0.010 |
Why?
|
| Acids | 1 | 1994 | 127 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 3461 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 12354 | 0.010 |
Why?
|
| Electrolytes | 1 | 1994 | 282 | 0.010 |
Why?
|
| Birth Weight | 1 | 2001 | 2069 | 0.010 |
Why?
|
| Gestational Age | 1 | 2001 | 3493 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1998 | 2421 | 0.010 |
Why?
|
| Serine | 1 | 1996 | 826 | 0.010 |
Why?
|
| Asthma | 1 | 1991 | 6011 | 0.010 |
Why?
|
| Permeability | 1 | 1994 | 738 | 0.010 |
Why?
|
| Haplotypes | 1 | 1998 | 2779 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 6459 | 0.010 |
Why?
|
| Antibodies, Fungal | 1 | 1991 | 32 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1993 | 621 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 1991 | 94 | 0.010 |
Why?
|
| Aged | 1 | 2023 | 163280 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 5102 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 2645 | 0.010 |
Why?
|
| Vasodilation | 1 | 1993 | 944 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 2557 | 0.010 |
Why?
|
| Skin Tests | 1 | 1991 | 613 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6622 | 0.000 |
Why?
|
| Arteries | 1 | 1993 | 1119 | 0.000 |
Why?
|
| Research Design | 1 | 2004 | 5987 | 0.000 |
Why?
|
| Water | 1 | 1994 | 1395 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1996 | 2440 | 0.000 |
Why?
|
| Seasons | 1 | 1991 | 1493 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1991 | 1463 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1996 | 8436 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 19905 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1993 | 4199 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1991 | 1199 | 0.000 |
Why?
|
| Heart Rate | 1 | 1993 | 4091 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1993 | 8554 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1991 | 4234 | 0.000 |
Why?
|